Kwaliteitsstandaard Primaire Scleroserende Cholangitis (PSC)

Kwaliteitsstandaard PSC Pagina 94 van 117 Versie 1.0 76. Rudolph, G., Kloeters-Plachky, P., Rost, D., and Stiehl, A. The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid. Eur J Gastroenterol Hepatol. 2007; 19: 487491 77. Said K, Glaumann H, Bergquist A. Gallbladder disease in patients with primary sclerosing cholangitis. J Hepatol 2008;48:598–605. 78. Schaafsma F, Hulshof C, Verbeek J, Bos J, Dyserinck H, van Dijk F. Developing search strategies in Medline on the occupational origin of diseases. (Etiologie van beroepsgebonden aandoeningen) Amer J Ind Med 2006;49:127-37. 79. Stiehl, A. Ursodeoxycholic acid therapy in treatment of primary sclerosing cholangitis. Scand J Gastroenterol Suppl. 1994; 204: 5961 80. Stiehl, A., Rudolph, G., Klo-ters-Plachky, P., Sauer, P., and Walker, S. Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. J Hepatol. 2002; 36 81. Stiehl, A., Rudolph, G., Sauer, P., Benz, C., Stremmel, W., Walker, S. et al. Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study. J Hepatol. 1997; 26 82. Tischendorf JJ, Hecker H, Krüger M, Manns MP, Meier PN. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study. Am J Gastroenterol. 2007;102:107–114. 83. Tol JA, van Hooft JE, Timmer R, Kubben FJ, van der Harst E, de Hingh IH, Vleggaar FP, Molenaar IQ, Keulemans YC, Boerma D, et al. Metal or plastic stents for preoperative biliary drainage in resectable pancreatic cancer. Gut. 2016;65:1981–1987. 84. Trikudanathan G, Navaneethan U, Njei B et al. Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta- analysis. Gastrointest Endosc 2014; 79: 783-789 85. Tung, B.Y., Emond, M.J., Haggitt, R.C., Bronner, M.P., Kimmey, M.B., Kowdley, K.V. et al. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med. 2001; 134: 8995 86. Vajda I. Visiedocument Concentratie en organisatie van zorg bij zeldzame aandoeningen. VSOP 2015. 87. Varekamp I, Hulshof CTJ, van Dijk FJH, van Vliet C. EBM voor de bedrijfsarts: zoekstrategieën voor de internationale literatuur over moeilijk objectiveerbare aandoeningen. Werk gerelateerde aspecten van moeilijk objectiveerbare aandoeningen. TBV 2005;13:343-347.